85
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Docetaxel-related interstitial pneumonitis

, &
Pages 1813-1816 | Published online: 09 Dec 2015
 

Abstract

Docetaxel (Taxotere®) is an agent that is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer. In recent years, docetaxel-related interstitial lung disease (ILD) has been reported in several case series studies. The onset of ILD occurred ~10–20 days (median time: 18 days) after docetaxel administration. Here, we reported the case of a patient who had pulmonary toxicity of ILD within 3 days after using a relatively low-dose docetaxel administration. Although some articles have described patients who progressed to respiratory failure and needed intubation, this patient responded well to steroid treatment and discontinued docetaxel administration.

Disclosure

The authors report no conflicts of interest in this work.